General Description
Mestranol is a synthetic estrogen, specifically the 3-methyl ether of ethinylestradiol. It is a prodrug that requires hepatic demethylation to become active ethinylestradiol. The molecule is a 19-nortestosterone derivative with an ethinyl group at the 17α position and a methoxy group at the 3-position.
Mechanism of Action
As a prodrug, mestranol is converted to ethinylestradiol, which binds to estrogen receptors (ERα and ERβ) in target tissues. The receptor complex regulates transcription of genes involved in the reproductive cycle. In oral contraceptives, the estrogen component inhibits gonadotropin (FSH and LH) secretion via negative feedback, preventing ovulation. Mestranol itself has very low affinity for estrogen receptors; its activity depends entirely on bioactivation.
Application
Mestranol was used as the estrogenic component of combined oral contraceptives for pregnancy prevention and for the management of menstrual disorders. It is also employed in some menopausal hormone therapy preparations. Compared to ethinylestradiol, mestranol has a slightly longer half-life due to the demethylation step, but it is also less potent on a milligram basis.